Cagrilintide (Long-Acting Amylin Analog)
No pricing data available yet for this peptide.
Pricing data is updated regularly.
Long-acting amylin analog that activates amylin receptors in the brain to promote satiety, slow gastric emptying, and reduce food intake. Being developed in combination with semaglutide (CagriSema) for enhanced weight loss effects beyond GLP-1 alone.
| Level | Amount | Frequency | Timing |
|---|---|---|---|
| Beginner | 0.25 mg | Weekly | Subcutaneous injection, any time of day |
| Standard | 1.0 mg | Weekly | Subcutaneous injection, same day each week |
| Advanced | 2.4 mg | Weekly | Subcutaneous injection, same day each week |
Ongoing under medical supervision. Dose titrated over 16+ weeks.
~7 days (supports weekly dosing)
Pre-filled pen. No reconstitution needed.
Refrigerate 36-46°F. In-use pens can be stored at room temperature for up to 21 days.
N/A - pre-filled pen
Explore peer-reviewed studies and clinical research on Cagrilintide
Peer-reviewed medical research
Active and completed clinical trials
Academic papers and citations
Evidence-based supplement analysis
Research Disclaimer: These links lead to external research databases. Always consult with a qualified healthcare provider before making decisions based on research literature.
This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment recommendation. Consult a licensed healthcare professional before using any peptide. BioProtocol does not sell peptides or pharmaceutical products.